Bailard
SNY icon

Bailard’s Sanofi SNY Stock Holding History

Bailard’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.06M Sell
25,750
-746
-3% -$32.5K 0.02% 337
2026
Q2 		$1.13M Sell
26,496
-2,295
-8% -$103K 0.02% 334
2026
Q1 		$1.39M Buy
28,791
+1,849
+7% +$86.2K 0.03% 276
2025
Q4 		$1.31M Sell
26,942
-114
-0.4% -$5.65K 0.03% 285
2025
Q3 		$1.28M Sell
27,056
-1,879
-6% -$90.7K 0.03% 300
2025
Q2 		$1.4M Buy
28,935
+1,199
+4% +$61.3K 0.03% 280
2025
Q1 		$1.54M Buy
27,736
+11,377
+70% +$616K 0.04% 249
2024
Q4 		$789K Buy
16,359
+220
+1% +$11.2K 0.02% 340
2024
Q3 		$930K Buy
16,139
+173
+1% +$9.34K 0.02% 319
2024
Q2 		$775K Sell
15,966
-533
-3% -$25.7K 0.02% 338
2024
Q1 		$802K Buy
16,499
+1,232
+8% +$60.2K 0.02% 340
2023
Q4 		$759K Sell
15,267
-346
-2% -$16.9K 0.02% 342
2023
Q3 		$837K Sell
15,613
-1,356
-8% -$72.3K 0.03% 296
2023
Q2 		$915K Buy
16,969
+23
+0.1% +$1.24K 0.03% 278
2023
Q1 		$922K Buy
16,946
+1,455
+9% +$70.8K 0.03% 279
2022
Q4 		$750K Buy
15,491
+1,814
+13% +$79.6K 0.03% 307
2022
Q3 		$520K Sell
13,677
-1,332
-9% -$59.4K 0.02% 358
2022
Q2 		$751K Buy
15,009
+341
+2% +$18.1K 0.03% 284
2022
Q1 		$753K Sell
14,668
-24
-0.2% -$1.24K 0.03% 323
2021
Q4 		$736K Sell
14,692
-1,289
-8% -$63.8K 0.02% 325
2021
Q3 		$770K Buy
15,981
+543
+4% +$27.6K 0.03% 313
2021
Q2 		$813K Buy
15,438
+568
+4% +$29.6K 0.03% 308
2021
Q1 		$735K Buy
14,870
+1,084
+8% +$52.1K 0.03% 307
2020
Q4 		$670K Buy
13,786
+1,689
+14% +$83.3K 0.03% 265
2020
Q3 		$607K Buy
12,097
+380
+3% +$19.6K 0.03% 260
2020
Q2 		$598K Buy
11,717
+1,188
+11% +$57.7K 0.03% 251
2020
Q1 		$460K Buy
+10,529
New +$504K 0.03% 239

Other funds holding SNY

Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Willis Investment Counsel
Willis Investment Counsel Gainesville, Georgia $1.97B AUM 25.29% 1-Year Est. Return
Foundation Resource Management
Foundation Resource Management Little Rock, Arkansas $939M AUM 37.7% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $687M AUM 18.35% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Baker Ellis Asset Management
Baker Ellis Asset Management Vancouver, Washington $917M AUM 26.82% 1-Year Est. Return
Fulton Bank
Fulton Bank Lancaster, Pennsylvania $3.29B AUM 13.65% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Bailard's SNY Position: Q3 2026 in Review

Bailard reduced its Sanofi (SNY) stake by 2.8% in Q3 2026, selling an estimated $32.5K and leaving 25,750 shares worth $1.06M. The position accounts for 0.02% of the portfolio, ranked #337.

Bailard first reported a position in SNY in Q1 2020 and has held it in 27 quarters since. The position peaked at $1.54M in Q1 2025. 116 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Bailard held 25,750 shares of Sanofi worth $1.06M as of Q3 2026.
  • Bailard sold 746 Sanofi shares in Q3 2026, an estimated $32.5K.
  • Sanofi made up 0.02% of Bailard's portfolio in Q3 2026, its #337 holding.
  • Bailard first reported a position in Sanofi in Q1 2020 and has held it in 27 quarters since.
  • Bailard's Sanofi position peaked at $1.54M in Q1 2025.
  • 116 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.